RANKL Induces IL-18 Binding Protein Expression in RAW264.7 Cells

  • Takahashi Yumi
    Nihon University Graduate School of Dentistry
  • Tanaka Hideki
    Department of Oral Health Sciences, Nihon University School of Dentistry Division of Functional Morphology, Dental Research Center, Nihon University School of Dentistry
  • Nakai Kumiko
    Department of Oral Health Sciences, Nihon University School of Dentistry Division of Functional Morphology, Dental Research Center, Nihon University School of Dentistry
  • Kitami Satoshi
    Department of Oral Health Sciences, Nihon University School of Dentistry
  • Murakami Fumiko
    Nihon University Graduate School of Dentistry
  • Morita Toyoko
    Department of Oral Health Sciences, Nihon University School of Dentistry The Lion Foundation for Dental Health
  • Tanabe Natsuko
    Division of Functional Morphology, Dental Research Center, Nihon University School of Dentistry Department of Biochemistry, Nihon University School of Dentistry
  • Kawato Takayuki
    Department of Oral Health Sciences, Nihon University School of Dentistry Division of Functional Morphology, Dental Research Center, Nihon University School of Dentistry
  • Maeno Masao
    Department of Oral Health Sciences, Nihon University School of Dentistry Division of Functional Morphology, Dental Research Center, Nihon University School of Dentistry

Search this article

Description

The receptor activator of NF-κB (RANK) ligand (RANKL) is a cytokine that is essential for osteoclast development, whereas interleukin (IL)-18 suppresses osteoclastogenesis by increasing granulocyte-macrophage colony-stimulating factor (GM-CSF) production in T-cells. In the present study, we examined the effect of RANKL on the expression of IL-18 and IL-18 binding protein (IL-18BP), a natural inhibitor of IL-18, in RAW264.7 cells. We also examined the effect of conditioned medium derived from RAW264.7 cells on IL-18-induced GM-CSF expression in CD4+ T cells isolated from the spleens of C57BL/6J mice. mRNA expression of IL-18 was significantly suppressed, whereas that of IL-18BP was significantly increased in RANKL-treated RAW264.7 cells compared with untreated cells. RANKL also increased the expression of IL-18BP protein in culture supernatants of RAW264.7 cells. GM-CSF protein expression in CD4+ T-cells stimulated with IL-18 was suppressed by the addition of conditioned medium derived from RANKL-treated RAW264.7 cells. These results suggest that RANKL suppresses the stimulatory effect of IL-18 on GM-CSF expression in CD4+ T-cells via enhancing the production of IL-18BP in RAW264.7 cells.

Journal

Citations (2)*help

See more

References(35)*help

See more

Details 詳細情報について

Report a problem

Back to top